| 41.30 Data as of May 22 |  -0.51 / -1.22%Today’s Change | 32.69 Today|||52-Week Range 44.44 | +1.13% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $2.1B |
Company Description
Haemonetics Corp. is a global healthcare company dedicated to providing innovative blood management solutions for its customers. Together, the company's devices and consumables, information technology platforms and consulting services deliver a suite of business solutions to help for the customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients. The company's technologies address important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Its devices help ensure a safe and adequate blood supply and assist blood centers and hospitals in their efforts to operate efficiently and in compliance with regulatory requirements. The company was founded in 1971 and is headquartered in Braintree, MA.
Employees
Shareholders
| Mutual fund holders | 56.17% |
| Other institutional | 46.41% |
| Individual stakeholders | 1.20% |
Top Executives
| Brian P. Concannon | President, Chief Executive Officer & Director |
| Christopher J. Lindop, CPA | Chief Financial Officer & VP-Business Development |
| Jonathan T. White, MD, MBA | Vice President-Research & Development |
| Sandra L. Jesse | Secretary, Chief Legal Officer & Vice President |
| Stephen C. Swenson | Vice President & General Manager-Global Plasma |
.
